← Return to Suzetrigine - a novel drug for pain

Discussion

Suzetrigine - a novel drug for pain

Chronic Pain | Last Active: 11 hours ago | Replies (210)

Comment receiving replies
@heisenberg34

It looks to me as if this Journavxn is a "Pie-i-the-Sky" drug that may never live up to the hype. Like many new drugs, the initial cost is prohibitive. Even if the price comes down, it doesn't appear to be effective for neuropathic pain.

Jump to this post


Replies to "It looks to me as if this Journavxn is a "Pie-i-the-Sky" drug that may never live..."

Could be,,,the research on diabetic neuropathy is, I believe in the phase 3 trial...Who knows if it will continue to be funded..The research for a phase 3 trial for lumbar radiculopathy, after a poorly designed phase 2 trial.was meant to proceed I'm sure that funding is in jeopardy, as well. My experience thus far, which clearly means nothing in terms of broader efficacy, was 50mg 2x's a day did nothing discernible. At my pain doctors urging I tried 100mg 2x's a day. I continued taking Celebrex once a day and tylenol arthritis 2x's a day. Adding Journvx made a difference. Having said that there could be unforeseen side effects at this dose....a risk I would take but it is unaffordable.